JP2011519876A5 - - Google Patents

Download PDF

Info

Publication number
JP2011519876A5
JP2011519876A5 JP2011507805A JP2011507805A JP2011519876A5 JP 2011519876 A5 JP2011519876 A5 JP 2011519876A5 JP 2011507805 A JP2011507805 A JP 2011507805A JP 2011507805 A JP2011507805 A JP 2011507805A JP 2011519876 A5 JP2011519876 A5 JP 2011519876A5
Authority
JP
Japan
Prior art keywords
pyridin
hydroxy
thieno
dihydro
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011507805A
Other languages
English (en)
Japanese (ja)
Other versions
JP2011519876A (ja
JP5536757B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2009/002606 external-priority patent/WO2009135580A1/en
Publication of JP2011519876A publication Critical patent/JP2011519876A/ja
Publication of JP2011519876A5 publication Critical patent/JP2011519876A5/ja
Application granted granted Critical
Publication of JP5536757B2 publication Critical patent/JP5536757B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011507805A 2008-05-05 2009-04-08 Ampにより活性化されたプロテインキナーゼ(ampk)アクチベーターとしてのチエノピリドン誘導体 Expired - Fee Related JP5536757B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP08290423 2008-05-05
EP08290423.6 2008-05-05
PCT/EP2009/002606 WO2009135580A1 (en) 2008-05-05 2009-04-08 Thienopyridone derivatives as amp-activated protein kinase (ampk) activators

Publications (3)

Publication Number Publication Date
JP2011519876A JP2011519876A (ja) 2011-07-14
JP2011519876A5 true JP2011519876A5 (enExample) 2012-06-07
JP5536757B2 JP5536757B2 (ja) 2014-07-02

Family

ID=40756916

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011507805A Expired - Fee Related JP5536757B2 (ja) 2008-05-05 2009-04-08 Ampにより活性化されたプロテインキナーゼ(ampk)アクチベーターとしてのチエノピリドン誘導体

Country Status (26)

Country Link
US (1) US8604202B2 (enExample)
EP (1) EP2280952B1 (enExample)
JP (1) JP5536757B2 (enExample)
KR (2) KR101648593B1 (enExample)
CN (1) CN102015676B (enExample)
AR (1) AR071530A1 (enExample)
AU (1) AU2009243811B2 (enExample)
BR (1) BRPI0910832B8 (enExample)
CA (1) CA2723429C (enExample)
CO (1) CO6331304A2 (enExample)
CY (1) CY1113112T1 (enExample)
DK (1) DK2280952T3 (enExample)
EA (1) EA020773B1 (enExample)
EC (1) ECSP10010654A (enExample)
ES (1) ES2388485T3 (enExample)
HR (1) HRP20120549T1 (enExample)
IL (1) IL208988A (enExample)
MX (1) MX2010011916A (enExample)
MY (1) MY160357A (enExample)
NZ (1) NZ589690A (enExample)
PL (1) PL2280952T3 (enExample)
PT (1) PT2280952E (enExample)
SI (1) SI2280952T1 (enExample)
UA (1) UA103617C2 (enExample)
WO (1) WO2009135580A1 (enExample)
ZA (1) ZA201008722B (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2011107494A1 (de) 2010-03-03 2011-09-09 Sanofi Neue aromatische glykosidderivate, diese verbindungen enthaltende arzneimittel und deren verwendung
WO2011121109A1 (en) 2010-04-02 2011-10-06 INSERM (Institut National de la Santé et de la Recherche Médicale) Methods and compositions comprising ampk activator (metformin/troglitazone) for the treatment of myotonic dystrophy type 1 (dm1)
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
WO2012028582A1 (de) 2010-09-01 2012-03-08 Bayer Cropscience Ag Herbizid wirksame ketosultame und diketopyridine
EP2683690A1 (en) * 2011-03-07 2014-01-15 GlaxoSmithKline LLC Quinolinone derivatives
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760862B1 (en) 2011-09-27 2015-10-21 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
US8889730B2 (en) 2012-04-10 2014-11-18 Pfizer Inc. Indole and indazole compounds that activate AMPK
EP2679591A1 (en) * 2012-06-29 2014-01-01 Poxel Thienopyridone derivatives useful as activators of AMPK
JP6064062B2 (ja) 2013-03-15 2017-01-18 ファイザー・インク Ampkを活性化させるインダゾール化合物
EP3089748A4 (en) 2014-01-02 2017-09-27 Massachusetts Eye & Ear Infirmary Treating ocular neovascularization
WO2015114663A1 (en) 2014-01-30 2015-08-06 Council Of Scientific & Industrial Research Novel thieno [2,3-d]pyrimidin-4(3h)-one compounds with antimycobacterial properties
WO2016205534A1 (en) * 2015-06-16 2016-12-22 Lazo John S Inhibitors of ptp4a3 for the treatment of cancer
RS61919B1 (sr) 2015-06-25 2021-06-30 Univ Health Network Inhibitori hpk1 i postupci za njihovo korišćenje
CN108463218A (zh) 2015-09-30 2018-08-28 药物分子研究所 减弱寄生虫毒性的方法
US11584755B2 (en) 2017-09-26 2023-02-21 Ideaya Biosciences, Inc. Dihydrothieno[3,2-b]pyridine compounds
WO2019106087A1 (en) * 2017-11-29 2019-06-06 Syddansk Universitet Ampk inhibitors
MX2022014505A (es) 2020-05-19 2022-12-13 Kallyope Inc Activadores de la ampk.
CA3183575A1 (en) 2020-06-26 2021-12-30 Iyassu Sebhat Ampk activators
CN116322663A (zh) 2020-09-30 2023-06-23 比奥维拉迪维治疗股份有限公司 Ampk激活剂及其使用方法
WO2022106892A1 (en) 2020-11-17 2022-05-27 Instituto De Medicina Molecular Anti-malarial compounds
AU2022391025A1 (en) 2021-11-19 2024-06-06 The Brigham And Women's Hospital, Inc. Bifunctional chimeric molecules for labeling of kinases with target binding moieties and methods of use thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8627698D0 (en) * 1986-11-20 1986-12-17 Boots Co Plc Therapeutic agents
DE4444815A1 (de) * 1994-12-15 1996-06-20 Merck Patent Gmbh Thienopyridone
AR040123A1 (es) * 2002-05-31 2005-03-16 Upjohn Co Compuestos tiofeno, antihelminticos e insecticidas
US7119205B2 (en) * 2003-05-16 2006-10-10 Abbott Laboratories Thienopyridones as AMPK activators for the treatment of diabetes and obesity
WO2006093518A2 (en) * 2004-06-25 2006-09-08 Apath, Llc Thienyl compounds for treating virus-related conditions
US7563813B2 (en) * 2005-05-13 2009-07-21 Wyeth Iminothiazolidinone derivatives as SFRP-1 antagonists
EP1754483A1 (en) * 2005-08-18 2007-02-21 Merck Sante Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them
JP2009520015A (ja) 2005-12-20 2009-05-21 リヒター ゲデオン ニュルト 新規な化合物
KR101630466B1 (ko) * 2008-04-11 2016-06-14 메르크 파텐트 게엠베하 Amp-활성화 단백질 키나아제(ampk) 활성화제로서의 티에노피리돈 유도체

Similar Documents

Publication Publication Date Title
JP2011516510A5 (enExample)
HRP20120549T1 (hr) Derivati tienopiridona kao amp aktivirani aktivatori protein kinaze ampk
JP2013512277A5 (enExample)
JP5911514B2 (ja) 脂質低下抗糖尿病薬
RU2013107748A (ru) Производные с-арилглюкозидов, способ их получения и фармацевтическое применение
JP2009084270A5 (enExample)
JP2010500343A5 (enExample)
JP2015529229A5 (enExample)
JP2015523382A5 (enExample)
RU2011121876A (ru) Пиразолопиримидиновые соединения-ингибиторы jak и способы
JP2009507896A5 (enExample)
JP2012502037A5 (enExample)
JP2011516511A5 (enExample)
JP2014530818A5 (enExample)
JP2011506588A5 (enExample)
JP2008536833A5 (enExample)
TW201442702A (zh) 包含硝醯基予體的醫藥組合物
JP2010090149A5 (enExample)
JP2013518036A5 (enExample)
RU2015134420A (ru) Кристаллические формы { [1-циано-5-(4-хлорофеноксид)-4-гидроксид-изохинолин-3-карбонил]-амино} -уксусной кислоты
JP2011046708A5 (enExample)
JP2010532314A5 (enExample)
JP2018502829A5 (enExample)
RU2014114930A (ru) Новая терапия транстиретин-ассоциированного амилоидоза
JP2013513607A5 (enExample)